澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MAYNE PHARMA GROUP LTD

2.540

+0.0602.42%

成交量：39.71萬

成交額：99.38萬

市值：2.06億

市盈率：-2.42

高：2.550

開：2.500

低：2.440

收：2.480

52周最高：7.310

52周最低：2.350

股本：8,124.58萬

流通股本：6,699.72萬

量比：1.12

換手率：0.59%

股息：- -

股息率：- -

每股收益(TTM):-1.051

每股收益(LYR):-1.186

淨資產收益率：-20.58%

總資產收益率：-2.30%

市淨率：0.59

市盈率(LYR):-2.14

資料載入中...

總覽公司新聞資訊公告

Mayne製藥集團——將繼續推進產品組合規模化戰略，可能包含股票回購計劃

MAYNE PHARMA GROUP LTD上訴理由曝光，擬挑戰法院對該公司2025財年息税折舊攤銷前利潤等事項的裁決

Mayne Pharma收到Cosette及其Bidco向新南威爾士州最高法院上訴庭提交的上訴通知

MAYNE PHARMA GROUP LTD - 擴建生產設施正式啓用儀式在南澳大利亞薩爾斯堡舉行

Mayne Pharma Group Ltd - 與Cosette未能達成任何可能推進計劃的協議

Mayne Pharma Group Ltd - Mayne Pharma發布終止計劃實施契約的意向通知

澳大利亞以國家利益為由阻止科賽特收購梅恩製藥公司

澳大利亞財政部長：基於國家利益將阻止Cosette製藥收購MAYNE PHARMA GROUP LTD的提議

澳大利亞收購委員會發布最終命令，包括MAYNE PHARMA GROUP LTD同意財政部長對Salisbury合理要求的條件

澳大利亞收購委員會：6月24日至9月8日，市場未獲知Cosette在Salisbury地點的意向變更

澳大利亞收購委員會：Cosette在Salisbury的意圖變化意味着對MAYNE的控制市場未能按一般方式推進

澳大利亞收購委員會臨時命令限制Cosette在未經事先同意的情況下采取任何終止Sid的措施

澳大利亞收購委員會 - 在特定情況下，委員會認為維持現狀所需的臨時命令是必要的

澳大利亞收購委員會 - 臨時命令修訂MAYNE PHARMA GROUP LTD與Cosette Pharma之間的方案實施契約結束日期定義

Mayne Pharma Group Ltd - 外國投資審查委員會將Firb批准的法定截止日期延長至11月17日

Mayne Pharma - ASIC正式批准公司將2025年股東大會的召開時間從11月28日或之前延長至1月30日或之前

澳大利亞收購委員會 - Mayne尋求最終命令，包括Cosette同意將 FIRB 的決定法定截止日期延長至12月1日

澳大利亞收購委員會 - Mayne尋求臨時命令，包括Cosette向委員會確認將與Firb會面

澳大利亞財政部長考慮阻止科賽特競購後，梅因製藥股價大跌

梅因製藥股價下跌至38.6%，因澳大利亞財政部長考慮阻止收購要約

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MYX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":2.54,"timestamp":1772773920000,"preClose":2.48,"halted":0,"volume":397068,"delay":0,"changeRate":0.024193548387096794,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.051059,"marketStatus":"已收盤","change":0.06,"latestTime":"03-06 16:12:00 AEDT","open":2.5,"high":2.55,"low":2.44,"amount":993757,"amplitude":0.044355,"askPrice":2.57,"askSize":5000,"bidPrice":2.41,"bidSize":450,"shortable":3,"etf":0,"ttmEps":-1.051059,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1773010800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":2.48,"openAndCloseTimeList":[[1772751600000,1772773200000]],"volumeRatio":1.120476,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-2.30%","roe":"-20.58%","lyrEps":-1.185711,"volumeRatio":1.120476,"shares":81245827,"dividePrice":0,"high":2.55,"amplitude":0.044355,"preClose":2.48,"low":2.44,"week52Low":2.35,"pbRate":"0.59","psRate":"0.51","week52High":7.31,"institutionHeld":0,"latestPrice":2.54,"committee":-0.834862,"eps":-1.051059,"divideRate":0,"volume":397068,"delay":0,"ttmEps":-1.051059,"open":2.5,"prevYearClose":3.11,"prevWeekClose":2.52,"prevMonthClose":2.52,"prevQuarterClose":3.11,"fiveDayClose":2.52,"twentyDayClose":2.63,"sixtyDayClose":3.2,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null},{"date":"2024-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708902000000,"name":null,"time":"","dateTimestamp":1708866000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174229185","title":"Mayne製藥集團——將繼續推進產品組合規模化戰略，可能包含股票回購計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1174229185","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174229185?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 06:38","pubTimestamp":1771799894,"startTime":"0","endTime":"0","summary":"Mayne制药集团宣布将持续推进其产品组合的规模化战略，并透露未来可能采取包括股票回购在内的多元化举措。这一战略方向旨在优化公司资本结构并提升股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"1112976135","title":"MAYNE PHARMA GROUP LTD上訴理由曝光，擬挑戰法院對該公司2025財年息税折舊攤銷前利潤等事項的裁決","url":"https://stock-news.laohu8.com/highlight/detail?id=1112976135","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112976135?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 12:57","pubTimestamp":1768453037,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD已提交上诉通知书，其中列明的上诉理由旨在对法院就该公司2025财年息税折旧摊销前利润及其他相关财务指标所作出的认定提出异议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1175178833","title":"Mayne Pharma收到Cosette及其Bidco向新南威爾士州最高法院上訴庭提交的上訴通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1175178833","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175178833?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 12:56","pubTimestamp":1768453014,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd（ASX: MYX）近日宣布，已收到Cosette Pharmaceuticals及其关联收购实体（Bidco）向澳大利亚新南威尔士州最高法院上诉庭提交的上诉通知书。该上诉针对此前法院作出的相关裁决提出异议，标志着双方围绕商业纠纷的法律对抗进入新一轮司法程序。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"1124731935","title":"MAYNE PHARMA GROUP LTD - 擴建生產設施正式啓用儀式在南澳大利亞薩爾斯堡舉行","url":"https://stock-news.laohu8.com/highlight/detail?id=1124731935","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124731935?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 10:43","pubTimestamp":1765852990,"startTime":"0","endTime":"0","summary":"MAYNE PHARMA GROUP LTD - 扩建生产设施正式启用仪式在南澳大利亚萨尔斯堡举行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1146047415","title":"Mayne Pharma Group Ltd - 與Cosette未能達成任何可能推進計劃的協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1146047415","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146047415?lang=zh_tw&edition=fundamental","pubTime":"2025-12-03 14:40","pubTimestamp":1764744019,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd - 与Cosette未能达成任何可能推进计划的协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1129229249","title":"Mayne Pharma Group Ltd - Mayne Pharma發布終止計劃實施契約的意向通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1129229249","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129229249?lang=zh_tw&edition=fundamental","pubTime":"2025-12-03 14:39","pubTimestamp":1764743948,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd - Mayne Pharma发布终止计划实施契约的意向通知","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"2585647341","title":"澳大利亞以國家利益為由阻止科賽特收購梅恩製藥公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2585647341","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585647341?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 09:17","pubTimestamp":1763687820,"startTime":"0","endTime":"0","summary":"更新 1-澳大利亚以国家利益为由阻止科赛特收购梅恩制药公司全文更新，提供声明中的更多细节和背景情况Renju Jose/Christine Chen路透悉尼11月21日 - 澳大利亚周五阻止了美国制药商Cosette Pharmaceuticals对Mayne Pharma MYX.AX提出的6.72亿澳元 的收购要约，称该收购不符合国家利益。\"这是为了保护澳大利亚的国家利益、重要医疗供应链的安全、当地就业岗位和当地社区而采取的必要行动\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251121:nL4S3WX04N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"1101874220","title":"澳大利亞財政部長：基於國家利益將阻止Cosette製藥收購MAYNE PHARMA GROUP LTD的提議","url":"https://stock-news.laohu8.com/highlight/detail?id=1101874220","media":"美股速递","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101874220?lang=zh_tw&edition=fundamental","pubTime":"2025-11-21 07:46","pubTimestamp":1763682370,"startTime":"0","endTime":"0","summary":"澳大利亚财政部长：基于国家利益将阻止Cosette制药收购MAYNE PHARMA GROUP LTD的提议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"1104662603","title":"澳大利亞收購委員會發布最終命令，包括MAYNE PHARMA GROUP LTD同意財政部長對Salisbury合理要求的條件","url":"https://stock-news.laohu8.com/highlight/detail?id=1104662603","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104662603?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 16:04","pubTimestamp":1763539459,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会发布最终命令，包括MAYNE PHARMA GROUP LTD同意财政部长对Salisbury合理要求的条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1149255883","title":"澳大利亞收購委員會：6月24日至9月8日，市場未獲知Cosette在Salisbury地點的意向變更","url":"https://stock-news.laohu8.com/highlight/detail?id=1149255883","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149255883?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 16:04","pubTimestamp":1763539459,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会：6月24日至9月8日，市场未获知Cosette在Salisbury地点的意向变更","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1170023886","title":"澳大利亞收購委員會：Cosette在Salisbury的意圖變化意味着對MAYNE的控制市場未能按一般方式推進","url":"https://stock-news.laohu8.com/highlight/detail?id=1170023886","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170023886?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 16:02","pubTimestamp":1763539331,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会：Cosette在Salisbury的意图变化意味着对MAYNE的控制市场未能按一般方式推进","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1134813682","title":"澳大利亞收購委員會臨時命令限制Cosette在未經事先同意的情況下采取任何終止Sid的措施","url":"https://stock-news.laohu8.com/highlight/detail?id=1134813682","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134813682?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 12:51","pubTimestamp":1763095870,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会临时命令限制Cosette在未经事先同意的情况下采取任何终止Sid的措施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"1167970201","title":"澳大利亞收購委員會 - 在特定情況下，委員會認為維持現狀所需的臨時命令是必要的","url":"https://stock-news.laohu8.com/highlight/detail?id=1167970201","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167970201?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 12:50","pubTimestamp":1763095823,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - 在特定情况下，委员会认为维持现状所需的临时命令是必要的","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1157529952","title":"澳大利亞收購委員會 - 臨時命令修訂MAYNE PHARMA GROUP LTD與Cosette Pharma之間的方案實施契約結束日期定義","url":"https://stock-news.laohu8.com/highlight/detail?id=1157529952","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157529952?lang=zh_tw&edition=fundamental","pubTime":"2025-11-14 12:50","pubTimestamp":1763095813,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - 临时命令修订MAYNE PHARMA GROUP LTD与Cosette Pharma之间的方案实施契约结束日期定义","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7096","BK7508"],"gpt_icon":0},{"id":"1175509821","title":"Mayne Pharma Group Ltd - 外國投資審查委員會將Firb批准的法定截止日期延長至11月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=1175509821","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175509821?lang=zh_tw&edition=fundamental","pubTime":"2025-11-13 11:46","pubTimestamp":1763005569,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group Ltd - 外国投资审查委员会将Firb批准的法定截止日期延长至11月17日","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1199687473","title":"Mayne Pharma - ASIC正式批准公司將2025年股東大會的召開時間從11月28日或之前延長至1月30日或之前","url":"https://stock-news.laohu8.com/highlight/detail?id=1199687473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199687473?lang=zh_tw&edition=fundamental","pubTime":"2025-11-07 14:46","pubTimestamp":1762497972,"startTime":"0","endTime":"0","summary":"Mayne Pharma - ASIC正式批准公司将2025年股东大会的召开时间从11月28日或之前延长至1月30日或之前","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"1180672738","title":"澳大利亞收購委員會 - Mayne尋求最終命令，包括Cosette同意將 FIRB 的決定法定截止日期延長至12月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=1180672738","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180672738?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 15:35","pubTimestamp":1762414512,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - Mayne寻求最终命令，包括Cosette同意将 FIRB 的决定法定截止日期延长至12月1日","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"gpt_icon":0},{"id":"1130202281","title":"澳大利亞收購委員會 - Mayne尋求臨時命令，包括Cosette向委員會確認將與Firb會面","url":"https://stock-news.laohu8.com/highlight/detail?id=1130202281","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130202281?lang=zh_tw&edition=fundamental","pubTime":"2025-11-06 15:34","pubTimestamp":1762414452,"startTime":"0","endTime":"0","summary":"澳大利亚收购委员会 - Mayne寻求临时命令，包括Cosette向委员会确认将与Firb会面","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2579766456","title":"澳大利亞財政部長考慮阻止科賽特競購後，梅因製藥股價大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2579766456","media":"路透中文","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579766456?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 17:18","pubTimestamp":1761902334,"startTime":"0","endTime":"0","summary":"更新 1-澳大利亚财政部长考虑阻止科赛特竞购后，梅因制药股价大跌财政部长称收购可能违背国家利益据媒体报导，珂赛特关闭梅恩阿德莱德工厂的计划可能导致200个工作岗位流失投资者警告称，该决定可能阻碍澳大利亚未来的并购交易重铸并通过Scott Murdoch路透10月31日 - 周五，梅恩制药MYX.AX的股价暴跌近三分之一，因为有消息称澳大利亚财政部长正在考虑阻止现在不情愿的收购方Cosette Pharmaceuticals对该公司提出的6.72亿澳元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nL4T3WC0TC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MYX.AU","BK7096"],"gpt_icon":0},{"id":"1193649617","title":"梅因製藥股價下跌至38.6%，因澳大利亞財政部長考慮阻止收購要約","url":"https://stock-news.laohu8.com/highlight/detail?id=1193649617","media":"美股速递","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193649617?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 07:25","pubTimestamp":1761866710,"startTime":"0","endTime":"0","summary":"梅因制药的股价下跌至38.6%，原因是澳大利亚财政部长考虑是否阻止该公司的收购要约。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYX.AU","BK7508","BK7096"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}